News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wei Lin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Wei Lin (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 4,200 shares
@ $0
Granted 8,450 options to buy
@ $11.81, valued at
$99.8k
|
|
| 03/09/2023 |
4
| Wei Lin (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 16,600 shares
@ $0
Granted 33,400 options to buy
@ $10.91, valued at
$364.4k
|
|
| 03/09/2023 |
3
| Wei Lin (Director) has filed a Form 3 on 2seventy bio, Inc. |
| 02/03/2023 |
4
| Wei Lin (Chief Medical Officer) has filed a Form 4 on Erasca, Inc.|
Txns:
| Acquired 1,748 shares
@ $4.097, valued at
$7.2k
Acquired 2 shares
@ $3.893, valued at
$7.8
Granted 560,000 options to buy
@ $4, valued at
$2.2M
|
|
| 07/15/2021 |
3
| Wei Lin (Chief Medical Officer) has filed a Form 3 on Erasca, Inc. |
|
|